CHRU de Lille

Running trials

• Recruiting

  Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Stem Cells Transplantation Recipients

  NCT07771855· Phase 2· Source

• Recruiting

  Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project

  NCT07418827· Source

• Recruiting

  Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery

  NCT06476184· Phase 3· Source

• Recruiting

  Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

  NCT06271057· Phase 2· Source

• Recruiting

  Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors

  NCT05649683· Source

• Recruiting

  Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

  NCT05246345· Source

• Active, not recruiting

  Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

  NCT04802590· Phase 2· Source

• Recruiting

  Dimensional and Developmental Profiles of Psychosis in Children and Adolescents

  NCT04370730· Source

• Active, not recruiting

  Monitoring to the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®

  NCT04159987· Source

• Recruiting

  A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort

  NCT03755726· Source

• Recruiting

  French Registry for Monitoring Pregnancies for Multiple Sclerosis

  NCT03900221· Source

• Active, not recruiting

  The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

  NCT03614260· Source

• Recruiting

  SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

  NCT02834884· Source

• Recruiting

  Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

  NCT02828202· Source

• Active, not recruiting

  Minimal SN Tumor Burden

  NCT01942603· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Melanoma2 recruiting
• Childhood cancers1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Haemophilia1 recruiting
• High blood pressure1 recruiting
• Multiple sclerosis1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting
• Ovarian cancer1 recruiting
• Schizophrenia1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

  NCT06488911· Phase 3· Source

• Completed

  Ophthalmological Adverse Events of Tralokinumab in AD

  NCT05682976· Source

• Completed

  Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis

  NCT05642208· Phase 4· Source

• Completed

  Objective and Perceived Health Status of Elderly People With Moderate or Severe Haemophilia in France: an Ancillary Study of the FranceCoag Registry

  NCT05218772· Source

• Terminated

  Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease

  NCT04217447· Phase 3· Source

• Terminated

  Interest of the Smartphone Application "MonCœur" in the Follow-up of Patients With Heart Failure

  NCT04198779· Source

• Completed

  Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy)

  NCT03901196· Source

• Completed

  Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation

  NCT03795298· Source

• Completed

  Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

  NCT03710876· Phase 3· Source

• Terminated

  Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia

  NCT03439371· Source

• Completed

  Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

  NCT03458260· Phase 2· Source

• Completed

  The TransCatheter Valve and Vessels Trial

  NCT03424941· Source

• Terminated

  MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis

  NCT03357562· Source

• Terminated

  Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels

  NCT03117972· Phase 2· Source

• Completed

  CardioMEMS HF System OUS Post Market Study

  NCT02954341· Source

• Completed

  Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)

  NCT02369731· Source

• Completed

  A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants

  NCT02075840· Phase 3· Source

• Completed

  SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients

  NCT02117167· Phase 2· Source

• Completed

  Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer

  NCT01658930· Source